R
Ronald Klein
Researcher at University of Wisconsin-Madison
Publications - 1306
Citations - 163459
Ronald Klein is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Population & Diabetes mellitus. The author has an hindex of 194, co-authored 1305 publications receiving 149140 citations. Previous affiliations of Ronald Klein include Los Angeles Biomedical Research Institute & Wake Forest University.
Papers
More filters
Journal ArticleDOI
Health-related quality of life before and after a breast cancer diagnosis
Amy Trentham-Dietz,Brian L. Sprague,Ronald Klein,Barbara E.K. Klein,Karen J. Cruickshanks,Dennis G. Fryback,John M. Hampton +6 more
TL;DR: It is suggested that breast cancer survivors experience relative declines in health-related QOL across a broad spectrum of domains, even many years after diagnosis.
Journal ArticleDOI
Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension.
TL;DR: Higher CRP levels are associated with PAD among US adults free of CVD, diabetes, and hypertension, and these results suggest that inflammatory mechanisms related to atherosclerosis may be operative even among clinically healthy adults.
Journal ArticleDOI
Aggregation of Refractive Error and 5-Year Changes in Refractive Error Among Families in the Beaver Dam Eye Study
TL;DR: The strong aggregation of refraction, including myopia and hyperopia, among siblings along with weaker associations among parent-child and cousin pairs and no associations among spouses suggest a potential genetic influence on refractive error.
Journal ArticleDOI
Three-Year Incidence and Cumulative Prevalence of Retinopathy: The Atherosclerosis Risk in Communities Study
Tien Yin Wong,Tien Yin Wong,Ronald Klein,F.M. Amirul Islam,Mary Frances Cotch,David Couper,Barbara E.K. Klein,Larry D. Hubbard,A. Richey Sharrett +8 more
TL;DR: Retinopathy signs occur frequently in middle-aged people, even in those without diabetes, and Hypertension and hyperglycemia are risk factors for incident retinopathy.
Journal ArticleDOI
Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B.
TL;DR: This research presents a novel probabilistic procedure called “spot-spot analysis” that allows for real-time analysis of the response of the immune system to Epstein-Barr virus.